Figure 5From: Sustained platelet-sparing effect of weekly low dose paclitaxel allows effective, tolerable delivery of extended dose dense weekly carboplatin in platinum resistant/refractory epithelial ovarian cancer Platelet count for patient 5 treated with weekly carboplatin AUC 3 and paclitaxel 20 mg/m 2 (hatched bars) and corresponding serum CA 125 (U/ml)(solid line). Dose omission (black bars).Back to article page